Switch to:
GuruFocus has detected 7 Warning Signs with Abbott Laboratories $ABT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Abbott Laboratories (NYSE:ABT)
Cash Flow from Financing
$11,147 Mil (TTM As of Dec. 2016)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2016, Abbott Laboratories paid $0 Mil more to buy back shares than it received from issuing new shares. It received $13,848 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $386 Mil paying cash dividends to shareholders. It received $42 Mil on other financial activities. In all, Abbott Laboratories earned $13,504 Mil on financial activities for the three months ended in Dec. 2016.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Abbott Laboratories's Cash from Financing for the fiscal year that ended in Dec. 2016 is calculated as:

Cash from Financing(A: Dec. 2016 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-522+13155+0+-1539+53
=11,147

Abbott Laboratories's Cash from Financing for the quarter that ended in Dec. 2016 is

Cash from Financing(Q: Dec. 2016 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=0+13848+0+-386+42
=13,504

Abbott Laboratories Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2016 was -1432 (Mar. 2016 ) + -179 (Jun. 2016 ) + -746 (Sep. 2016 ) + 13504 (Dec. 2016 ) = $11,147 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Abbott Laboratories's net issuance of stock for the three months ended in Dec. 2016 was $0 Mil. Abbott Laboratories paid $0 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Abbott Laboratories's net issuance of debt for the three months ended in Dec. 2016 was $13,848 Mil. Abbott Laboratories received $13,848 Mil from issuing more debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Abbott Laboratories's net issuance of preferred for the three months ended in Dec. 2016 was $0 Mil. Abbott Laboratories paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Abbott Laboratories's cash flow for dividends for the three months ended in Dec. 2016 was $-386 Mil. Abbott Laboratories spent $386 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Abbott Laboratories's other financing for the three months ended in Dec. 2016 was $42 Mil. Abbott Laboratories received $42 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Abbott Laboratories Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Net Issuance of Stock 191-1,082-826-867-77-2,364-1,605-2,195-2,237-522
Net Issuance of Debt -544-1,2393,7342,122-3,9774,4131,7927661,14713,155
Net Issuance of Preferred 0000000000
Dividends -1,959-2,174-2,414-2,671-2,938-3,183-882-1,342-1,443-1,539
Other Financing 01,0095093289691,850-6,0012929753
Cash from Financing -2,313-3,4861,002-1,088-6,023716-6,696-2,742-2,23611,147

Abbott Laboratories Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Net Issuance of Stock -1-1,346-1-2-888-519-1-200
Net Issuance of Debt -5031,004-70-504717-590295-39813,8480
Net Issuance of Preferred 0000000000
Dividends -335-364-360-359-360-385-384-384-3860
Other Financing 13915657503462-8938420
Cash from Financing -700-550-374-815-497-1,432-179-74613,5040
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK